Similar Articles for PMID: 21923736

Year	Number of Results
1988	1
1990	1
1991	1
1994	3
1995	1
1996	5
1997	3
1998	3
1999	6
2000	9
2001	8
2002	11
2003	11
2004	12
2005	9
2006	8
2007	9
2008	3
2009	4
2010	2
2011	5
2012	6
2013	1
2014	5
2015	7
2016	2
2017	3
2018	1
2019	3
2020	0

1

Variations in tissue selectivity amongst insulin secretagogues: a systematic review.

Abdelmoneim AS, Hasenbank SE, Seubert JM, Brocks DR, Light PE, Simpson SH. Abdelmoneim AS, et al. Diabetes Obes Metab. 2012 Feb;14(2):130-8. doi: 10.1111/j.1463-1326.2011.01496.x. Epub 2011 Nov 3. Diabetes Obes Metab. 2012. PMID: 21923736 Review.

2

The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.

Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S. Sunaga Y, et al. Eur J Pharmacol. 2001 Nov 9;431(1):119-25. doi: 10.1016/s0014-2999(01)01412-1. Eur J Pharmacol. 2001. PMID: 11716850

3

Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.

Hansen AM, Christensen IT, Hansen JB, Carr RD, Ashcroft FM, Wahl P. Hansen AM, et al. Diabetes. 2002 Sep;51(9):2789-95. doi: 10.2337/diabetes.51.9.2789. Diabetes. 2002. PMID: 12196472 Free article.

4

Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.

Gribble FM, Reimann F. Gribble FM, et al. J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):11-5. doi: 10.1016/s1056-8727(02)00272-6. J Diabetes Complications. 2003. PMID: 12623163 Review.

5

Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.

Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M. Dörschner H, et al. Mol Pharmacol. 1999 Jun;55(6):1060-6. doi: 10.1124/mol.55.6.1060. Mol Pharmacol. 1999. PMID: 10347249

6

Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.

Hu S, Wang S, Fanelli B, Bell PA, Dunning BE, Geisse S, Schmitz R, Boettcher BR. Hu S, et al. J Pharmacol Exp Ther. 2000 May;293(2):444-52. J Pharmacol Exp Ther. 2000. PMID: 10773014

7

Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.

Lim JG, Lee HY, Yun JE, Kim SP, Park JW, Suh SI, Jang BC, Cho CH, Bae JH, Kim SS, Han J, Park MJ, Song DK. Lim JG, et al. Biochem Pharmacol. 2004 Sep 1;68(5):901-10. doi: 10.1016/j.bcp.2004.05.050. Biochem Pharmacol. 2004. PMID: 15294453

8

Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.

Matsuo M, Tanabe K, Kioka N, Amachi T, Ueda K. Matsuo M, et al. J Biol Chem. 2000 Sep 15;275(37):28757-63. doi: 10.1074/jbc.M004818200. J Biol Chem. 2000. PMID: 10893240 Free article.

9

Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.

Chachin M, Yamada M, Fujita A, Matsuoka T, Matsushita K, Kurachi Y. Chachin M, et al. J Pharmacol Exp Ther. 2003 Mar;304(3):1025-32. doi: 10.1124/jpet.102.044917. J Pharmacol Exp Ther. 2003. PMID: 12604678

10

Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.

Winkler M, Stephan D, Bieger S, Kühner P, Wolff F, Quast U. Winkler M, et al. J Pharmacol Exp Ther. 2007 Aug;322(2):701-8. doi: 10.1124/jpet.107.123224. Epub 2007 May 10. J Pharmacol Exp Ther. 2007. PMID: 17495126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed